Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2020 Dec 31;14(12):e0008973. doi: 10.1371/journal.pntd.0008973

Utilization of government healthcare services by adult leprosy patients in the Western Province, Sri Lanka

Nadeeja Roshini Liyanage 1,*, Mahendra Arnold 2, Supun Wijesinghe 3
Editor: Linda B Adams4
PMCID: PMC7806162  PMID: 33382692

Abstract

Background

The leprosy services utilization by the patients at the clinic and field level should be high to achieve the target of eliminating leprosy as a public health problem in Sri Lanka. Furthermore, assessing patient and health system delay of a diagnosis and patient knowledge on disease are of equal importance to reveal the accurate picture.

Methods and findings

A descriptive cross-sectional study was conducted to assess the utilization of government healthcare services by 672 adult leprosy patients in Western Province (WP). Paucibacillary patients diagnosed at least six months and above, and Multibacillary patients diagnosed at least 12 months and above were selected by consecutive sampling method. An interviewer-administered questionnaire (IAQ) was used for data collection.

Clinic utilization by leprosy patients was 87.8%. The mean patient-related delay (time taken from the onset of symptoms to the encounter of a doctor/health facility for the first time) was 16.8 months and health care system delay (time taken from the date of clinic registration to start of treatment) was 21.2 days. The overall delay was 17.5 months. Services provided by the Medical Officer of Health (MOH) office for families affected with leprosy was known by 53.8% (n = 298) of patients. Majority of family contacts were examined at the hospitals (n = 299, 44%), 30.8% (n = 207) by the Public Health Inspectors (PHI) and 7% (n = 46) at the MOH offices. PHIs had visited 56.7% (n = 401) of the patient’s houses and 54% (n = 363) had received health education by PHI. Mean knowledge score was 50.7 (SD = 17.9). More than half (57.9%, n = 389) of the study sample had a good or very good knowledge level.

Conclusions

Utilization of clinic services was satisfactory. However, a considerable patient-related delay was found. Half of the patients were aware of available field services and a majority of contact screening was conducted at hospitals. Patient knowledge on leprosy was satisfactory.

Author summary

Leprosy is a chronic progressive bacterial infection caused by Mycobacterium Leprae. It mainly attacks the skin, peripheral nerves in the hands, feet and eyes, causing numbness or weakness of the affected area and resulting in chronic morbidities such as vision impairment, limb disability, trophic ulcers and nerve involvement. Leprosy is assumed to be spread via the respiratory system through nasal droplets. It is commonly found among people living in poor socioeconomic conditions. Therefore to prevent getting complications, early diagnosis and treatment is mandatory. Our aim was to identify any delays in diagnosis and treatment; whether patients are utilizing the existing facilities and to assess patient knowledge of the disease and treatment. Knowledge of the healthcare workers to identify the disease and patient knowledge to continue the treatment is of equal importance to reduce the case load, reduce the diagnostic delay and prevent developing complications. To find the reasons why the services are not utilized and communicate the true picture to the decision makers are the objectives of this study.

Introduction

Health care utilization is the measure of the population’s use of the health care services available to them [1,2]. Health care utilization and health status are indicators to measure how efficiently a health care system provides services in a population. Service utilization is the extent to which people are making use of the services that already exist in the community or at an organization [3,4,5]. The importance of assessing utilization of a health service is that the policymakers will be aware of the existing services and underutilized services which will help them to decide which services should be expanded or which should probably be discontinued. It will also assist health care providers in planning future programs and using their resources more effectively. Assessing service utilization is beneficial since it can be monitored and followed for any changes over time [6,7]. The knowledge of the patient affects their health seeking behavior [8]. If the patient has less knowledge of symptoms of the disease, mode of transmission and treatment, it will lead to delayed presentation to the health system or might end up with deformities.

Leprosy is a neglected tropical disease and approximately 2000 cases are reported annually in Sri-Lanka [9]. Assessing the healthcare service utilization of leprosy patients and finding the reasons behind underutilization will enable to explore the true status of the health care delivery and facilities. Following the integration of leprosy services to general health services in 2001/2002, leprosy cases are managed at dermatology clinics conducted in base hospitals and above with a Consultant Dermatologist [9]. Central Leprosy clinic (CLC) functions under Anti-Leprosy Campaign and is situated in the premises of the National Hospital of Sri Lanka (NHSL). It is specially designed to treat only leprosy patients from all over the country. It provides comprehensive patient care including diagnosis, management, skin smear testing, physiotherapy services, counselling services and wound care. Apart from CLC, there are three other dermatology clinics functioning in the NHSL. There is a leprosy clinic in the Prison Hospital Welikada, which provides services to the imprisoned patients. Furthermore, the Lady Ridgway Hospital for Children provides services for children. Additionally, leprosy treatment is provided in the dermatology clinics of Base hospitals and above throughout the country.

With regards to field-based services, leprosy became a notifiable disease in 2013 and contact tracing was started in 2014 in Sri Lanka. Medical Officer of Health (MOH) is responsible for preventive health services at the community level. The preventive services include reduction of active transmission of disease, lowering delayed presentation, improving quality clinic services, providing rehabilitating services, staff training and monitoring of the programme.

Since there are few studies carried out in the past in the proposed area, findings of the present study will provide the latest data in Sri Lanka on the utilization of services and knowledge of the disease of adult leprosy patients. The findings will be beneficial for healthcare planners in deciding future strategies, policy-making and implementation of new control activities.

Methods

Ethics statement

Ethical approval was obtained from the Ethics Review Committee of the Medical Research Institute, Colombo, Sri Lanka. Informed written consent was obtained from each participant prior to data collection. The consent of participants under the age of 18 was obtained from the participant as well as from the parent or guardian.

A descriptive cross-sectional study was carried out to assess the utilization of healthcare services by 705 adult leprosy patients who attended government leprosy clinics in the Western Province (WP) in the year 2018. A person 15 years and above was considered as an adult leprosy patient [10].

The service utilization in the clinic setting was operationally defined as “Attendance of leprosy patients to clinics regularly and continue treatment as prescribed”. For example, if an MB patient from the point of diagnosis to one year period attended the clinic for a minimum of 12 visits and PB patient from the point of diagnosis to six month period attended the clinic of minimum six visits, that patient’s clinic utilization was considered as 100%.

In 2015, the highest percentage (38%) of leprosy patients was reported from Western Province. Therefore WP was selected to conduct the study [9]. Among the nine provinces in Sri Lanka, WP reported the largest share of the population (28.7%) and it consists of Colombo, Gampaha and Kalutara districts [11]. The study was carried out in all leprosy clinics, dermatology clinics and households of leprosy patients. The study population consisted of all Paucibacillary adult leprosy patients diagnosed at least six months and above and, all Multibacillary adult leprosy patients diagnosed at least twelve months and above in the WP.

Clinic leprosy register was used as the sampling frame. Details of all the registered leprosy patients in the clinic were available in this register. Clinic leprosy register is maintained in every institution where leprosy patients are being treated. Consecutive sampling method was applied to select patients attending the clinic. Clinic attendance of patients was checked by refereeing to their clinic records.

Since the number of leprosy patients attending clinics is low, all eligible patients were recruited to achieve the required sample size. Adult leprosy patients not attending the clinic were traced from the details available in the clinic leprosy register and their data collection was carried out at the household level.

Interviewer administered questionnaire (IAQ) was used to assess the service utilization (S1 Text). It consists of socio-demographic data, information on disease and treatment, questions to assess the clinic and field utilization, and patient’s knowledge of leprosy. When assessing the knowledge on the disease and its transmission, marks were allocated in a way that each correct response got one mark, and no marks for incorrect or don’t know responses. The total score was calculated and the final marks were given as a percentage of the maximum marks allocated for the component. The knowledge score was categorized into four categories; less than 25% -very poor knowledge, 25%-49%—poor knowledge, 50–74%—good knowledge, and 75–100% -very good knowledge.

Results

There were 705 patients, of which 33 patients declined to consent to participate due to time constraints. Hence, the response rate was 95.3%. The study was carried out among 672 patients who attended the government leprosy clinics in the WP. Of the sample the highest number of patients (n = 534, 79.5%) were resided in the Colombo district and out of the 119 patients (17.7%) were from the Colombo Municipal Council area (CMC). Majority of patients (n = 290, 43.2%) were attended to the CLC (n = 290, 43.2%).

A large majority of the study sample were in the age group 30–44 years (n = 221, 32.9%), males (n = 419, 62.4%) and married (n = 489, 72.8%). The majority of the study sample consisted of patients educated up to Ordinary Level Examination (n = 269, 40%), in paid employment (n = 307, 45.7%) and those who were having a monthly family income of Rs 20,000- Rs.40,000[108–216$] (n = 328,48.8%) (Table 1).

Table 1. Distribution of patients by selected demographic and socioeconomic characteristics (n = 672).

Demographic & socioeconomic characteristics Frequency (n) Percentage (%)
Age Group(years)
 15–29 145 21.6
 30–44 221 32.9
 45–59 175 26.0
 60 or more 131 19.5
  (Mean = 43.8, SD = 16.1, Median = 42, Range = 15–94)
Sex
 Male 419 62.4
 Female 253 37.6
Marital status
 Married 489 72.8
 Unmarried 152 22.6
 Widowed 23 3.4
 Divorced 08 1.2
Level of Education
 No schooling 50 7.4
 Up to Grade 5 90 13.4
 Up to Grade 8 104 15.5
 Up to Ordinary Level 269 40.0
 Up to Advanced Level 144 21.4
 Tertiary education 15 2.2
Employment Status
 Unemployed 276 41.1
 Self-employed 89 13.2
 Paid employment 307 45.7
Monthly Family Income
 Less than Rs 20000(108$) 236 35.1
 Rs 20000–40000(108–216$) 328 48.8
 Rs 40001-60000(217–326$) 69 10.3
 More than Rs 60000(326$) 39 5.8

Disease type

The study sample consists of a higher proportion of Multibacillary patients (n = 473, 70.4%). Large proportion 607 (90.3%) of patients had initially experienced pale or reddish patches over the skin with loss of sensation as a symptom of leprosy. Over half of the patients obtained initial consultation at a government hospital (n = 393, 58.5%).

Patient and clinic-related delay

The mean patient-related delay (time taken from the onset of symptoms to the encounter of a doctor/health facility for the first time) is 16.8 months with a median of 8 months (Table 2). Mean time duration from presentation to a doctor to diagnosis is 18.6 days. Mean time duration from diagnosis to starting treatment is 2.7 days. Mean health care system delay (time taken from the date of clinic registration to start of treatment) is 21.2 days. Mean overall delay (time taken from the onset of symptoms to the start of treatment) is 17.5 months with a median of 8 months. Mean duration of patient-related delay was high among MB (17.9 months, SD = 36.5) patients compared to PB patients (14.1 months, SD = 21.7). Mean health care system delay was high among PB patients (31.2 days, SD = 234.8) when compared with MB patients (17.1 days, SD = 139.2). The overall delay was high among MB patients (18.5 months.SD = 36.6) when compared with PB patients (15.2 months, SD = 23.1).

Table 2. Distribution by delay of treatment initiation.

Levels of Delay Mean(SD) Median
Patient-related delay* 16.8(32.9) 8.0
Time from presentation to a doctor to diagnosis** 18.6(172.8) 0.0
Time from diagnosis to starting treatment** 2.7(9.8) 0.0
 Health care system delay** 21.2(173.0) 0.0
 Overall delay* 17.5(33.2) 8.0

*In months,

**In days

Service utilization

The percentage of clinic utilization by adult leprosy patients in the WP was 87.8%. Considering the utilization of the nearest clinic by patients, the majority had attended the nearest clinic to get leprosy treatment (n = 467, 69.5%) (Table 3). The most common reason for not attending the nearest clinic was to conceal the illness from known persons (n = 66, 32.2%). Of the patients, 32.2% (n = 66) believed that the faraway hospital provides better service and 24.8% (n = 51) wanted to continue treatment with the same specialist with whom the initial contact was made.

Table 3. Distribution by utilization of treatment services (n = 672).

Description Frequency Percentage
Attending to the nearest clinic (n = 672)
 Yes 467 69.5
 No 205 30.5
Reasons for not attending to the closest clinic (n = 205)
 To conceal the disease from known persons 66 32.2
 Believing the current hospital provide a better service 66 32.2
 To continue the treatment with the same specialist from the beginning 51 24.8
 Lack of laboratory facilities 14 6.8
 Other 8 4.0
Hospitalized during the course of treatment
 Yes 92 13.7
 No 580 86.3
Reason for admission(N = 92)
 To diagnose leprosy 24 26.0
 Fever with rash(Type 2 reaction) 24 26.0
 Wounds 09 9.8
 Dapsone induced hemolysis 06 6.6
 Surgery 06 6.6
 Numbness & swelling of the hands & feet 05 5.5
 Other 18 19.5
Period of hospitalization (N = 92)
 Less than seven days 62 67.4
 7–14 days 19 20.6
 15 days and above 11 12.0

Ninety-two patients (13.7%) were hospitalized during their course of treatment. Of the 39 (42.5%) were admitted to the National Hospital, Colombo. The most common reason for hospital admission was type 2 reaction with fever and rash (n = 24, 26%) and to diagnose leprosy (n = 24, 26%). The majority were hospitalized for less than seven days (n = 62, 67.4%).

Considering the provision of field health services, half of the sample (n = 338, 50.3%) were knowledgeable of the location of the MOH office (Table 4). Of the sample, 401 patients (56.7%) indicated that the PHI visited their houses and gave health education (n = 363, 54%) by PHI. In about 552 patients (82.2%) all family contacts were screened for leprosy. Among them, family members of 299 (44.4%)patients were examined at the hospital, 207 (30.8%) by PHI and 46 (7%)were examined at MOH offices. Screening of the family members were not done among 120(17.8%)patients. Among the patients, 482 (71.7%) consented to a home visit by health care workers. The main reason given by others for not permitting home visits by health care workers was to avoid neighbors knowing the disease condition (n = 167, 87.9%).

Table 4. Distribution by the provision of field health services, patient perception and awareness on field services (n = 672).

Description Frequency (n) Percentage (%)
MOH office has a role to provide services to leprosy-affected families
 Yes 298 44.3
 No 255 38.0
*Not relevant 119 17.7
Location of the MOH office
 Know 338 50.3
 Don’t know 215 32.0
*Not relevant 119 17.7
Family members examined by
 Hospital 299 44.4
 PHI 207 30.8
 MOH office 46 7.0
 Family member screening was not done 120 17.8
PHI visited the house
 Yes 401 56.7
 No 245 36.5
 No, but contacted over the phone and gave advice 26 3.8
Health education was given by PHI
 Yes 363 54.0
 No 309 46.0
Consented to home visit by health care workers
 Yes 482 71.7
 No 190 28.3
Reason for refusal of home visits (n = 190)
 To avoid neighbor’s knowing the disease condition 167 87.9
 Health workers may create unnecessary fear among family members 15 7.9
 Others 08 4.2

*Question is not relevant to patients from the Colombo Municipal Council (CMC) area

Knowledge of leprosy

When assessing the knowledge of patients regarding the disease, 288 (42.9%) said, leprosy is more prone to develop in people who are living in overcrowded houses (Table 5). Leprosy can be transmitted by nasal droplets of an affected person was known by 526 (78.3%) patients. A majority (n = 524, 78%) knew that leprosy can be transmitted by closely living with an affected person who is not on treatment. More than half of the sample (n = 351, 52.2%) knew that, leprosy cannot be transmitted by living with a person who is on treatment. Out of the patients, 645 (96%) knew hypo pigmented anesthetic patches are associated with leprosy. Majority of the sample (n = 576, 85.7%) knew that leprosy can be completely cured by taking regular treatment. According to the method mentioned in the calculation of total knowledge score (which ranged between 5–100), more than half (57.9%, n = 389) of the study sample had a good and very good knowledge level. Mean knowledge score was 50.7 (SD = 17.9) (S1 Data).

Table 5. Distribution by knowledge of leprosy.

Description Frequency (n = 672)
Correct Incorrect Don’t know
n (%) n (%) n (%)
Leprosy is more prone to develop in
 People with malnutrition 225(33.4) 114(17.0) 333(49.6)
 People with poverty 189(28.1) 152(22.6) 331(49.3)
 People living in overcrowded houses 288(42.9) 89(13.2) 295(43.9)
 Poor personal hygiene 248(36.9) 94(14.0) 330(49.1)
Leprosy can be transmitted by
 Nasal droplets of an affected person 526(78.3) 24(3.6) 122(18.1)
 Using the same toilet 29(4.4) 429(63.8) 214(31.8)
 Bath in the same well 18(2.7) 433(64.4) 221(32.9)
 Closely live with an affected person who is not on treatment 524(78.0) 26(3.9) 122(18.1)
 Genetically 47(7.0) 189(28.1) 436(64.9)
 Living with a person who is on treatment 62(9.3) 351(52.2) 259(38.5)
Leprosy patient can present with
 Hypo pigmented anesthetic patches 645(96.0) 4(0.6) 23(3.4)
 Nodules over the skin 137(20.4) 17(2.5) 518(77.1)
 Cough 43(6.4) 55(8.2) 574(85.4)
 Muscle weakness 76(11.3) 23(3.4) 573(85.3)
 Disability 107(15.9) 19(2.8) 546(81.3)
Other
 Ability to involved with social activities while on treatment 619(92.1) 23(3.4) 30(4.5)
 Leprosy leads to vision impairment in some patients 320(47.6) 72(10.7) 280(41.7)
 Leprosy does not affect the nerve function 129(19.2) 276(41.1) 267(39.7)
 Leprosy leads to disability and disfigurement if left untreated 554(82.4) 41(6.1) 77(11.5)
 Leprosy can be completely cured by taking regular treatment 576(85.7) 33(4.9) 63(9.4)

Discussion

The Sri Lankan government provides free health services for all citizens. Therefore, the majority of the Sri Lankan population rely on government health services [12,13]. This is reflected among leprosy patients in the present study; over half of the patients obtained initial consultation at a government hospital. Once diagnosed, all patients have to attend government dermatology clinics since only government hospitals provide treatment for leprosy. Patients were referred to dermatology clinics from Out Patient Department (OPD)s of government and private hospitals, general practitioners, MOH’s, and PHIs in the field and during School Medical Inspections (SMI). The number of patients referred by PHI may be comparatively low due to low contact examination coverage by PHIs, since the PHI is only able to examine males and their clinical knowledge and skills to identify disease may not be adequate. PHI is a grass root level public health officer who provides services in a vast health related areas apart from the disease notification and contact tracing. Being a male and not accompanying female with him during home visits, when he encounters a female leprosy contact, she is not examined and referred to a Medical Officer at MOH office or to a Dermatology clinic.

Patient-related delays occur not only due to patients’ fault but also due to lack of experience by health care workers to detect the disease condition [14,15,16]. Health care staff coming across leprosy patient is a rare event since the total number of cases is low in Sri Lanka. Leprosy is confined to some areas of urban slums among low socio-economic community. Improving the awareness of leprosy of health staff and the community is important to overcome this problem [17,18]. Usually, at government hospitals, MDT drugs are started on the same day, for patients who can be diagnosed clinically followed by Slit Skin Smear test. If the diagnosis is doubtful, the clinic staff has to take a biopsy and wait for the results. The time duration for this will vary between 2–6 weeks in different hospitals. Health care system delay arises due to this process. If the first biopsy report is inconclusive, a further period is required for the second biopsy.

Some of the Dermatology clinics in the government hospitals are overcrowded with patients. Furthermore, dermatology clinics provide services to leprosy as well as to other dermatological conditions. Usually, the hypo pigmented patches arise due to leprosy are pain free/symptomless. Therefore, patients are reluctant to spend a half day in a dermatology clinic to diagnose it, which leads to patient related delay.

A study carried out by Nicholos et al [19] in India (Purulia) and Bangladesh (Nilphamari), in patients currently receiving treatment for leprosy revealed; delay estimated from time of the first symptoms to start of effective treatment had a mean of 18 months (median nine months) in Purulia and mean of 20 months (median 12 months) in Nilphamari. In the current study, the mean delay was 17.5 months (median of 8 months) which shows similar results. This reflects the poor community awareness of leprosy symptoms in South Asian countries. This is significant since many patients with delays in the presentation will end up with deformities. Furthermore, Zhang et al. [8] carried out a study in China, and the total mean delay was 50·2 months (median 36 months). The mean patient delay was 24·4 months (median 9·5 months) and the mean health service delay was 25·7 months (median 12 months). In the current study mean total delay was 17.5 months (median eight months), mean patient-related delay 16.8 months (median of eight months) and mean health care system delay was 21.2 days, which are less than the Chinese study. In a study carried out by Deps et al. in Brazil [20] the mean delay in MB (27·2 months) was greater than in PB (21·3 months). The current study shows a similar pattern but with lower duration (mean delay of the MB patients 18.5 months and PB patients it was 15.2 months). These findings reflect an increase in awareness and health-seeking behavior of the Sri Lankan population compared to the Chinese and Brazilian population.

However, according to the Sri Lanka Anti Leprosy Campaign data 2015, 44.7% of patients presented to the clinic as late presentations (>6 months). Percentage of early diagnosis (< 6 months) of cases in Colombo, Gampaha and Kalutara district in 2015 were 43%, 48% and 48% respectively [9]. These statistics means nearly half of the patients present late to the clinics in Sri Lanka.

Clinic utilization by Paucibacillary patients was 87.9% (n = 199) and in Multibacillary patients it was 87.7% (n = 473). Clinic utilization of both categories was more or less similar and satisfactory. A study carried out in India by Renita et al. [21] on health care utilization by leprosy patients revealed the clinic utilization was 58·1%(n = 115). In the current study, clinic utilization was higher than the Indian study. It reflects the increased health-seeking behavior of the Sri Lankan population. This concept highlights that once diagnosed, educated and counseled properly, the patients tend to attend a clinic and continue the treatment except those with poor family support and special cases such as drug addicts, prisoners etc.

As stated above, the Sri Lankan health care system is well established and people trust the government healthcare service. Therefore, a majority of patients (69.5% (n = 467)) utilized the nearest government clinic. Furthermore, basic diagnostic facilities are available in the majority of the Dermatology clinics. Nevertheless, only half of the sample knew the location of the MOH office. These findings indicate that only half of the patients were aware of field health services. Nearly one-third of patients (n = 190, 28.3%) were refusing of home visits by health care workers.

Some of the patients were hiding their disease from family members due to stigma. Moreover, they refused visit by the health workers due to fear of revealing the disease. In such instances, range PHI of the area organized a skin clinic close to patient’s residence to cover the community in the area, including patient family members. However this highlights the importance of a need for a mechanism developed to screen family contacts.

The study had some limitations. The study participants had been on continuous treatment for some time. As a result of that, they were continuously getting health education from the hospital staff regarding the disease. This may be one reason of them having a high knowledge level. Furthermore, the study findings are applicable only to the Western province of Sri Lanka. It cannot be generalized to the other parts of the country.

Conclusion

Clinic utilization by adult leprosy patients in the WP was satisfactory. There was a long patient-related delay in attending a hospital and a considerable health system delay for starting treatment. More than half of the study sample had a good knowledge of disease transmission, symptoms and complications of the disease. Nearly half of the sample was aware of the services provided to leprosy patients at the MOH office and by PHI. Although contact screening was satisfactory, nearly one third of patients did not consent to a home visit by health care workers. Majority of the contacts were examined at hospital clinics.

For early disease identification, it is recommended to conduct regular awareness and training to GPs, OPD Doctors, MOH’s and field health workers (such as PHIs and PHMs). To minimize patient-related delay, a community awareness program including mass media campaign should be conducted. Mandatory contact tracing by strengthening the legislative aspect and reinforce contact screening activities in all MOH offices will improve the number of cases diagnosed further.

Supporting information

S1 Text. Study Questionair on Utilization of healthcare services by leprosy patients.

(DOCX)

S1 Data. Data set.

(XLSX)

Acknowledgments

The authors would like to express gratitude to the experts who gave support to plan this study and health staff in the dermatology clinics and MOH offices and, data collectors.

Data Availability

Data cannot be shared publicly due to the patient confidential information included in it. The datasets used and/or analysed are available from the Ethics Review Committee of the Medical Research Institute, Colombo 08. (Project No 55/2017. Email: erc_mri2016@hotmail.com.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.University of Manitoba, Canada, Term: Health care utilization, 2010, http://mchpappserv.cpe.umanitoba.ca/viewDefinition.php?definitionID=102752
  • 2.Carrasquillo O. Health Care Utilization In: Gellman MD, Turner JR, editors. Encyclopedia of Behavioral Medicine. Springer;2013. New York, NY: https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-10059_885#howtocite [Google Scholar]
  • 3.World Health Organization. Health Service Delivery. Geneva: WHO; 2010;P2 https://www.who.int/healthinfo/systems/WHO_MBHSS_2010_section1_web.pdf
  • 4.Eek F, Merlo J, Gerdtham U, Lithman T. Health Care Utilisation and Attitudes towards Health Care in Subjects Reporting Environmental Annoyance from Electricity and Chemicals. Pell J, editor. J Environ Public Health [Internet]. 2009:106389. 10.1155/2009/106389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.National academies of Sciences, Engineering and Medicine. Health care utilization as a Proxy in Disability Determination, Washinton, DC: The National Academies Press; 2018; 10.17226/24969. [DOI] [PubMed]
  • 6.Da Silva RB, Contandriopoulos AP, Pineault R, Tousignant P. A global approach to evaluation of health services utilization: concepts and measures. Healthcare policy = Politiques desante. 2011; 6(4):e106–e117. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107120/#ffn_sectitle [PMC free article] [PubMed] [Google Scholar]
  • 7.Shi-Yi W, Li-Kuei C, Sylvia HH, Shih-Chieh W. Health care utilization and health outcomes: a population study of Taiwan. Health Policy and Planning.2012. October;27(7):P590–599. 10.1093/heapol/czr080 [DOI] [PubMed] [Google Scholar]
  • 8.Zhang F, Chen S, Sun Y, Chu T. Healthcare seeking behaviour and delay in diagnosis of leprosy in a low endemic area of China. Lepr Rev. 2009. December;80(4):416–23. [PubMed] [Google Scholar]
  • 9.Leprosy A, Pai CAM. Anti-Leprosy Campaign (ALC) Annual Report 2015. 2015;6,7,14. https://www.leprosycampaign.health.gov.lk/index.php/en/gallery/annual-reports
  • 10.College of Dermatologist. Guidelines on Management of Leprosy, Sri Lanka. Ministry of Health and Indigenous Medicine; 2013. p 17.
  • 11.Census of Population and Housing Sri Lanka, 2012. http://www.statistics.gov.lk/PopHouSat/CPH2011/Pages/Activities/Reports/SriLanka.pdf
  • 12.United Nations Sri Lanka, 2016. https://lk.one.un.org/7060/en/free-health-policy-in-sri-lanka
  • 13.Perera S. Primary Health Care Reforms in Sri Lanka: Aiming at Preserving Universal Access to Health In: Medcalf A, Bhattacharya S, Momen H, et al. , editors. Health for All: The Journey of Universal Health Coverage. Hyderabad (IN): Orient Blackswan; 2015. Chapter 10. https://www.ncbi.nlm.nih.gov/books/NBK316262/ [PubMed] [Google Scholar]
  • 14.Libardo G, Alberto R, Yesenia V, Jorge B, Christa K, Sandra P, et al. Factors associated with the delay of diagnosis of leprosy in north-eastern Colombia: a quantitative analysis. Tropical Medicine and International Health. 2018. February; 23 (2): pp 193–198. 10.1111/tmi.13023 [DOI] [PubMed] [Google Scholar]
  • 15.Henry M, GalAn N, Teasdale K, Prado R, Amar H. Factors Contributing to the Delay in Diagnosis and Continued Transmission of Leprosy in Brazil—An Explorative, Quantitative, Questionnaire Based Study. PLoS Neglected Tropical Diseases. 2016; 10(3): e0004542 10.1371/journal.pntd.0004542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Muthuvel T, Govindarajulu S, Isaakidis P, Shewade HD, Rokade V, Singh R, et al. "I Wasted 3 Years, Thinking It’s Not a Problem": Patient and Health System Delays in Diagnosis of Leprosy in India: A Mixed-Methods Study. PLoS neglected tropical diseases. 2017: 11(1): e0005192 10.1371/journal.pntd.0005192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lockwood DNJ, Reid AJC. The diagnosis of leprosy is delayed in the United Kingdom QJM: An International Journal of Medicine.2001. April; 94(4):P207–212. 10.1093/qjmed/94.4.207 [DOI] [PubMed] [Google Scholar]
  • 18.Natasja HJ, Van V, Abraham M, Jan HR. The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia. Lepr Rev. 2006: 77: P 356–365 [PubMed] [Google Scholar]
  • 19.Nicholls PG, Chhina N, Bro AK, Barkataki P, Kumar R, Withington SG, et al. Factors contributing to delay in diagnosis and start of treatment of leprosy: analysis of help-seeking narratives in northern Bangladesh and in West Bengal, India. Lepr Rev. 2005. March;76(1):35–47. [PubMed] [Google Scholar]
  • 20.Deps PD, Guedes BVS, Filho JB, Andreatta MK, Marcari RS, Rodrigues LC. Delay in the diagnosis of leprosy in the Metropolitan Region of Vitoria, Brazil. Lepr Rev. 2006; 77: 41–47. [PubMed] [Google Scholar]
  • 21.Renita L, Pulimood SA, Eapen EP, Muliyil J, John KR. Health care utilisation in Indian leprosy patients in the era of elimination. Lepr Rev. 2010. December;81(4):299–30 [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008973.r001

Decision Letter 0

Linda B Adams, Gerson Oliveira Penna

2 Oct 2020

Dear Dr. Liyanage,

Thank you very much for submitting your manuscript "Utilisation of Government Healthcare Services by Adult Leprosy Patients in the Western 

Province, Sri Lanka" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Linda B Adams

Associate Editor

PLOS Neglected Tropical Diseases

Gerson Penna

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: This study covers an important area in diagnosis of leprosy, namely the delay in diagnosis of leprosy. since delay in diagnosis can directly affect subsequent disability in leprosy the study is of importance and relevance to NTD s.

Reviewer #2: The authors clearly state their primary objective to determine the utilization of leprosy health services by patients. However, they do not discuss their secondary objective of testing patient's leprosy knowledge until the methods section. The authors should discuss both objectives in the abstract and introduction sections and especially discuss the role that general knowledge or lack of knowledge about leprosy may play in impacting the accessibility of health services. The authors describe the study population adequately although it is slightly unclear about the role of the clinic's leprosy register in patient recruitment. Otherwise, the study design, sample size, and analyses were well done and properly addressed the objectives.

Reviewer #3: Yes

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: results are in keeping with he analysis plan. The results are clearly mentioned. I have requested one clarification of a statement.

Reviewer #2: Analyses and the results were explained thoroughly. All of the tables were well designed and easy to understand and interpret. Only correction in the Results was that at several points the authors refer to a "Type 11" reaction, which is confusing. I would recommend correcting that to be "Type 2" to improve clarity.

Reviewer #3: Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: the conclusions are clearly mentioned and supported by the data presented.

Reviewer #2: The conclusions presented are supported by the data presented, however the authors need to further expand on the significance of these conclusions both for Sri Lanka and for the global leprosy field. Additionally, while the authors offer informative comparisons of their results to the results of studies conducted in other countries, they do not discuss any limitations of their own study.

Reviewer #3: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: the Author summary was not clearly presented. I have taken the liberty to make some modifications. The modified version is attached.

Reviewer #2: There are a few minor grammatical errors throughout the manuscript. Additionally, the second half of the author summary is a little awkward. I understand what the authors are trying to say, but I think a few sentences could be reworded to improve clarity.

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The study is of relevance since delay in diagnosis of leprosy is of importance to all endemic countries.

Reviewer #2: Overall, this is a well-written manuscript of an interesting cross-sectional study of healthcare utilization by leprosy patients in the Western Province of Sri Lanka. The results are interesting, and the study was thoroughly conducted. However, I felt that the authors needed to expand on their discussion of how these results affect both Sri Lanka and the field of leprosy research. The authors started to do this with an interesting comparison of their results to other similar studies conducted in other countries. However, they did not discuss why their results were better or worse than those seen elsewhere. For instance, what programs or healthcare factors affect these outcomes? More discussion on these factors could really help to show why their results are relevant both in Sri Lanka and also globally.

Reviewer #3: (No Response)

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Srinivas G

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

Attachment

Submitted filename: PLOS review.docx

Attachment

Submitted filename: Review of Liyanage, N. 2020 manuscript.pdf

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008973.r003

Decision Letter 1

Linda B Adams, Gerson Oliveira Penna

10 Nov 2020

Dear Dr. Liyanage,

We are pleased to inform you that your manuscript 'Utilization of Government Healthcare Services by Adult Leprosy Patients in the Western Province, Sri Lanka' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Linda B Adams

Associate Editor

PLOS Neglected Tropical Diseases

Gerson Penna

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008973.r004

Acceptance letter

Linda B Adams, Gerson Oliveira Penna

21 Dec 2020

Dear Dr. Liyanage,

We are delighted to inform you that your manuscript, "Utilization of Government Healthcare Services by Adult Leprosy Patients in the Western  Province, Sri Lanka," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Study Questionair on Utilization of healthcare services by leprosy patients.

    (DOCX)

    S1 Data. Data set.

    (XLSX)

    Attachment

    Submitted filename: PLOS review.docx

    Attachment

    Submitted filename: Review of Liyanage, N. 2020 manuscript.pdf

    Attachment

    Submitted filename: 2020 11 01 Correction sheet.docx

    Data Availability Statement

    Data cannot be shared publicly due to the patient confidential information included in it. The datasets used and/or analysed are available from the Ethics Review Committee of the Medical Research Institute, Colombo 08. (Project No 55/2017. Email: erc_mri2016@hotmail.com.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES